Hi there,

In coming days Democracy Now! will continue to bring you post-election results and in-depth analysis on on the impact of the coming Trump administration. Because Democracy Now! does not accept corporate advertising or sponsorship revenue, we rely on viewers like you to feature voices and analysis you won’t get anywhere else. Can you donate $15 to Democracy Now! today to support our post-election coverage? Right now, a generous donor will DOUBLE your gift, which means your $15 donation is worth $30. Please help us air in-depth, substantive coverage of the outcome of the election and what it means for our collective future. Thank you so much! Every dollar makes a difference.

-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

House GOP Drops Medicare Cost Inquiry

HeadlineApr 02, 2004

The Los Angeles Times is reporting that House Republicans have shut down an inquiry by Democrats on whether the Bush administration mislead Congress on the true costs of last year’s Medicare prescription drug bill.

The Democrats were attempting to force the White House to allow two top officials connected to Medicare to answer questions regarding the charges that Medicare’s former administrator, Thomas Scully, threatened to fire a top actuary if he revealed the actual costs.

But for the second time in recent weeks the White House claimed there was a longstanding policy against having White House staff testify before Congress. The Bush administration had also used this excuse to justify its initial refusal to allow National Security Advisor Condoleezza Rice testify publicly before the 9/11 commission.

Scully, the former head of Medicare, said he couldn’t testify because he has been too busy traveling. Scully left government soon after the Medicare bill was passed to take a lucrative job working for law firms that represent pharmaceutical interests that benefited from the new law.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top